MyFinsight
Home
Blog
About
Contact
Download
Download image
Prepaid expense and
other current assets
$7,499K
Receivables from related
parties
$226K
Short-term marketable
securities
$59,544K
Cash and cash
equivalents
$408,741K
Restricted cash
$132K
Other non-current
assets
$5,384K
Operating lease
right-of-use asset
$2,440K
Property and equipment,
net
$827K
Total current assets
$476,010K
Total assets
$484,793K
Total liabilities,
redeemable convertible...
$484,793K
Total stockholders'
equity (deficit)
$446,700K
Total liabilities
$38,093K
Accumulated deficit
-$317,770K
Accumulated other
comprehensive income
$36K
Additional paid-in capital
$764,426K
Operating lease
liability, noncurrent
$2,381K
Total current
liabilities
$35,712K
Common stock, 0.0001
par value...
$8K
Other accrued
liabilities
$178K
Operating lease
liability, current
$506K
Payables to related
parties
$691K
Accrued professional
services
$2,091K
Accrued research and
development liabilities
$24,107K
Accrued compensation
and benefits
$4,489K
Accounts payable
$3,650K
Back
Back
Balance Sheet
source: myfinsight.com
BridgeBio Oncology Therapeutics, Inc. (BBOT)
BridgeBio Oncology Therapeutics, Inc. (BBOT)